{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:54:53Z","timestamp":1786589693552,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institute of General Medical Sciences of National Institutes of Health","award":["P30GM114736"],"award-info":[{"award-number":["P30GM114736"]}]},{"name":"Japan Agency for Medical Research and development, AMED","award":["JP18gk0110017"],"award-info":[{"award-number":["JP18gk0110017"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ymgme.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T20:14:10Z","timestamp":1530994450000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Critical review of current MPS guidelines and management"],"prefix":"10.1016","volume":"126","author":[{"given":"Molly","family":"Stapleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Hoshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Sawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9330-0154","authenticated-orcid":false,"given":"Francyne","family":"Kubaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Theroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orii","family":"Tadao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2018.07.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170365","article-title":"Clinical practice guidelines for rare diseases: the orphanet database","volume":"12","author":"Pavan","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project","volume":"12","author":"Terrace","year":"2003","journal-title":"Qual. Saf. Health Care"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0020","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jpeds.2009.07.005","article-title":"Guidelines for the management of mucopolysaccharidosis type I","volume":"155","author":"Martins","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with Mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0035","first-page":"CD009354","article-title":"Enzyme replacement with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I","volume":"9","author":"Jameson","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0040","author":"Australian Government Department of Health"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0050","first-page":"CD008185","article-title":"Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (hunter syndrome)","volume":"9","author":"da Silva","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ymgme.2018.07.001_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","article-title":"The role of enzyme replacement therapy in severe hunter syndrome- an expert panel consensus","volume":"171","author":"Muenzer","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0060","author":"Australian Government Department of Health"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0065","series-title":"Practical Guideline for the Management of Mucopolysaccharidosis (MPS) Type II","author":"Eto","year":"2017"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/21678707.2017.1296761","article-title":"Presentation and treatments for Mucopolysaccharidosis type II (MPS II; hunter syndrome)","volume":"5","author":"Stapleton","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0075","author":"Brazilian Health Ministry"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0080","first-page":"S77","article-title":"Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis type II","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0085","first-page":"62","article-title":"Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: a 7 years follow-up","volume":"12","author":"Barth","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0095","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0105","first-page":"141","article-title":"Morquio asyndrome: diagnosis and current and future therapies the pathogenesis of systemic skeletal dysplasia in Morquio a syndrome remains an enigmatic","volume":"12","author":"Tomatsu","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"173","key":"10.1016\/j.ymgme.2018.07.001_bb0110","article-title":"A systematic review of the prevalence of Morquio a syndrome: challenges for study reporting in rare diseases","volume":"9","author":"Leadley","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.a.36833","article-title":"International guidelines for the management and treatment of Morquio a syndrome","volume":"167","author":"Hendriksz","year":"2015","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0120","author":"National Institute for Health Care and Excellence"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0125","first-page":"78","article-title":"Mucopolysaccharidosis IVA and glycosaminoglycans","volume":"120","author":"Khan","year":"2017","journal-title":"HHS Public Access"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0130","first-page":"14","article-title":"Home infusion with Elosulfase alpha (Vimizim R) in a UK Paediatric setting","author":"Finnigan","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0145","author":"Australian Government Department of Health"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0150","first-page":"CD009806","article-title":"Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI","volume":"3","author":"Brunelli","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0155","author":"Food and Drug Administration"},{"issue":"2","key":"10.1016\/j.ymgme.2018.07.001_bb0160","first-page":"S59","article-title":"Enzyme replacement therapy (ERT) for mucopolysaccharidosis VII (MPS VII; Sly syndrome) reduces lysosomal storage in a 36-week phase 1\/2 clinical study","volume":"114","author":"Jones","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2018.07.001_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Monta\u00f1o","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2018.07.001_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.a.20314","article-title":"Incidence of the mucopolysaccharidoses in Western Australia","volume":"123A","author":"Nelson","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0180","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"228","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis. Internet"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0185","series-title":"Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil: A Multicenter Study. Value in Health Regional Issues","first-page":"99","volume":"8","author":"de Bitencourt","year":"2015"},{"issue":"3","key":"10.1016\/j.ymgme.2018.07.001_bb0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajmg.a.38073","article-title":"Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I","volume":"173","author":"Nestrasil","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2018.07.001_bb0195","first-page":"53","article-title":"Emerging treatment options for the mucopolysaccharidoses","volume":"2","author":"Giugliani","year":"2012","journal-title":"Res. Rep. Endocr. Disord."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218303585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218303585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:22:25Z","timestamp":1761088945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218303585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1096719218303585"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.07.001","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical review of current MPS guidelines and management","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}